• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    AlgoTx Completes Phase II Trial Of ATX01 In Neuropathy

    GLOBENEWSWIRE

    Algo Announces Initiation of Global Phase 2 Clinical Trial of ATX01

    BUSINESSWIRE

    AlgoTherapeutix Completes Phase I for ATX01, Poised for Phase II in 2022

    BUSINESSWIRE

    AlgoTherapeutix Receives Regulatory Approval to Initiate Clinical DevPt of ATX01

    BUSINESSWIRE

    AlgoTherapeutix Receives Regulatory Approval to Clinical Devept of ATX01

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.